Are there any causes for increased thyroid volume in women with prolactinoma?

Basit Öğe Kaydı
dc.contributor.authorDogan, Bercem Aycicek
dc.contributor.authorTasci, Tugba
dc.contributor.authorArduc, Ayse
dc.contributor.authorTuna, Mazhar Muslum
dc.contributor.authorBerker, Dilek
dc.contributor.authorGuler, Serdar
dc.date.accessioned2024-04-24T16:10:47Z
dc.date.available2024-04-24T16:10:47Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractPurpose. - The aim of this study was to evaluate thyroid volume in women with prolactinoma and investigate the relationship between anabolic hormones [insulin, insulin like growth factor (IGF-1), estrogen] and thyroid volume in the patients. Material-method. - Sixty-three euthyroid women with prolactinoma and 60 healthy euthyroid women were included. Serum prolactin (PRL), thyroid-stimulating hormone (TSH), thyroxine (free T4), free tri-iodothyronine (free T3), insulin resistance (IR) which was estimated by the homeostasis model assessment, thyroidal microsome (anti-TPO), antithyroglobulin antibodies (TgAb), estradiol (E2), and insulin like growth factor (IGF-1) were evaluated, and thyroid volume was calculated by B-mode doppler USG. Results. - The mean thyroid volume was significantly higher in women with prolactinoma (82.5 +/- 15.1 mL) than in healthy women (76 +/- 15.1 mL)(P = 0.014), but no correlation was found between thyroid volume and serum PRL levels (P = 0.967). There were also no differences between thyroid volume, anabolic hormones (E2, IGF-1), and insulin resistance in women with prolactinoma (P = 0.776, P = 0.786, P = 0.647, respectively). Conclusions. - Our study did not show an association between anabolic hormones and increased thyroid volume in women with prolactinoma. (C) 2015 Elsevier Masson SAS. All rights reserved.en_US
dc.identifier.doi10.1016/j.ando.2014.12.003
dc.identifier.endpage600en_US
dc.identifier.issn0003-4266
dc.identifier.issn2213-3941
dc.identifier.issue5en_US
dc.identifier.pmid26067294
dc.identifier.scopus2-s2.0-84947026096
dc.identifier.scopusqualityQ2
dc.identifier.startpage595en_US
dc.identifier.urihttps://doi.org/10.1016/j.ando.2014.12.003
dc.identifier.urihttps://hdl.handle.net/11468/15111
dc.identifier.volume76en_US
dc.identifier.wosWOS:000367122600002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherMasson Editeuren_US
dc.relation.ispartofAnnales D Endocrinologie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnabolic Hormonesen_US
dc.subjectProlactinomaen_US
dc.subjectThyroid Volumeen_US
dc.titleAre there any causes for increased thyroid volume in women with prolactinoma?en_US
dc.titleAre there any causes for increased thyroid volume in women with prolactinoma?
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu